Interferon Beta-1b for the Treatment of Multiple Sclerosis – More than 10 Years of Experience
Authors
Laura Iulia Barcutean
University of Medicine, Pharmacy, Sciences and Technology of Târgu Mureş, Romania
Mures County Emergency Clinical Hospital, Department of Neurology, Târgu Mureş, Romania
Smaranda Maier
University of Medicine, Pharmacy, Sciences and Technology of Târgu Mureş, Romania
Mures County Emergency Clinical Hospital, Department of Neurology, Târgu Mureş, Romania
Zoltan Bajko
University of Medicine, Pharmacy, Sciences and Technology of Târgu Mureş, Romania
Mures County Emergency Clinical Hospital, Department of Neurology, Târgu Mureş, Romania
Anca Motataianu
University of Medicine, Pharmacy, Sciences and Technology of Târgu Mureş, Romania
Mures County Emergency Clinical Hospital, Department of Neurology, Târgu Mureş, Romania
Andreea Romaniuc
Mures County Emergency Clinical Hospital, Department of Neurology, Târgu Mureş, Romania
Sebastian Razvan Andone
Mures County Emergency Clinical Hospital, Department of Neurology, Târgu Mureş, Romania
Rodica Ioana Balasa
University of Medicine, Pharmacy, Sciences and Technology of Târgu Mureş, Romania
Mures County Emergency Clinical Hospital, Department of Neurology, Târgu Mureş, Romania
Language: English
Page range: 12 - 18
Submitted on: Nov 14, 2018
Accepted on: Mar 5, 2019
Published on: Mar 29, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2019 Laura Iulia Barcutean, Smaranda Maier, Zoltan Bajko, Anca Motataianu, Andreea Romaniuc, Sebastian Razvan Andone, Rodica Ioana Balasa, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.